| Literature DB >> 18033686 |
Chien-Hung Lee1, Jang-Ming Lee, Deng-Chyang Wu, Yih-Gang Goan, Shah-Hwa Chou, I-Chen Wu, Ein-Long Kao, Te-Fu Chan, Meng-Chuan Huang, Pei-Shih Chen, Chun-Ying Lee, Chia-Tsuan Huang, Hsiao-Ling Huang, Chih-Yang Hu, Yu-Hsiu Hung, Ming-Tsang Wu.
Abstract
The consumption of alcohol, tobacco and betel quid has been found to be an important contributor to esophageal squamous cell carcinoma (ESCC) in Taiwan. The genotoxic effect of the ADH1B and ALDH2 genes modulating an individual's alcohol-metabolizing capacity on ESCC may be linked to drinking behavior, intake pattern and other exogenous factors. To investigate the interplay of these genetic and environmental factors in determining the risk of ESCC, a multicenter case-control study was conducted. Here, 406 patients with pathology-proven ESCC, as well as 656 gender, age and study hospital matched controls were recruited. Genetic polymorphisms of ADH1B and ALDH2 appeared to correlate with the abstinence of alcohol, though not with tobacco and betel quid. Within the same levels of alcohol consumption, carcinoma risks increased along with an increase in the numbers of ADH1B*1 and ALDH2*2 alleles. The inactive ALDH2*1/*2 genotype was found to multiplicatively interact with a low-to-moderate (0.1-30 g/day) and a heavy (>30 g/day) ethanol intake to increase the ESCC risk (the joint aOR = 14.5 and 102.6, respectively). Among low-to-moderate drinkers, a smoking-dependent carcinogenetic effect for the ADH1B*1/*1 and ALDH2*1/*2+*2/*2 genotypes was recognized, with significant risks found in smokers, but not in nonsmokers. Further, a supra-multiplicative combined risk of ESCC for alcohol and tobacco use was identified among carriers of the ADH1B*1/*1 genotype (p for interaction = 0.042). In conclusion, the interplay of the ADH1B and ALDH2 genotypes, in conjunction with a behaved drinking habit and a practiced drinking pattern, along with continued tobacco consumption, plays an important pathogenic role in modulating ESCC risk. (c) 2007 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18033686 DOI: 10.1002/ijc.23264
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396